|
Non-Canonical Functions of Hexokinase 3 During Myeloid Differentiation
Kristina SEILER, Scripps Research, United States
|
|
Pancreatic ductal adenocarcinoma requires PI3K? activity to accelerate circulating DNA-positive metastatic disease.
Fernanda RAMOS-DELGADO, CRCT , France
|
|
Targeting Mitochondrial Iron Metabolism Re-Sensitizes Resistant Acute Myeloid Leukemia Cells to Cytarabine
Estelle SALAND, Inserm U1037, France
|
|
A drug-tolerant senescent-like state promotes EGFR-TKI resistance and can be targeted with Rho/AKT inhibitors
Sarah FIGAROL, Cancer Research Center of Toulouse, France
|
|
A new role for cytidine deaminase in the control of DNA replication and genome stability in pancreatic cancer cells
Audrey LUMEAU, CRCT-10, France
|
|
Psychological and social impact of adapted physical activity (APA), namely touch rugby, in patients followed for gynecological and breast cancer
Kelig VERGRIETE, Centre Hospitalier Universitaire , France
|
|
PI3K? signaling controls the balance between tissue regeneration and precancer lesion formation via PHGDH expression in pancreatic inflammation.
Coralie CAYRON, CRCT, France
|
|
Evaluating PRL2 as a new target for glioblastoma treatment
Tiffanie CHOULEUR, INSERM U1029 - Université de Bordeaux, France
|
|
Molecular profiling of Midostaurin-resistant leukemic cells using CRISPR-Cas9 screening
Solène FERNANDEZ, U1035 BMGIC- Université de Bordeaux, France
|
|
RIP140 participates in the transcriptional interplay between p53 and HIF-2alpha to regulate glucose metabolism in cancer cells
Catherine TEYSSIER, Institut de Recherche en Cancérologie de Montpellier, France
|
|
Microtubule associated proteins as predictive biomarkers of taxane-based chemotherapy in high-grade serous ovarian cancer
Hadia MOINDJIE, Institut Gustave Roussy, France
|
|
Cancer cells replication program flexibility in response to replication stress
Lilas COURTOT, CRCT INSERM 1037, France
|
|
Long Noncoding RNAs in NPM1-mutated cytogenetically normal acute myeloid leukemia: clinical relevance and functional characterization
Morgane GOURVEST, Centre de Recherches en Cancérologie de Toulouse - CRCT, France
|
|
Ceramide metabolism alterations in TNF-induced resistance to immune checkpoint blockers in melanoma
Carine DUFAU, CRCT Inserm 1037, France
|
|
A new role of CEBPA in Acute Myeloid Leukemia : from differentiation to lipid and mitochondrial metabolism
Marie SABATIER, CRCT - Inserm UMR1037, France
|
|
Tumor adaptation of oncolytic virus to overcome pancreatic cancer resistance to treatment
Pierre CORDELIER, INSERM U1037 équipe 10, France
|
|
Towards precision Medicine: How bladder PDX models can support therapeutic decisions
Yolande MISSERI, Urosphere, France
|
|
Free-5S particles as new anti-cancer therapeutic target
Simon LEBARON, CBI-INSERM, France
|
|
LOSS OF WSX-1 EXPRESSION THROUGH MIR-324-5P OVEREXPRESSION IS AN INDEPENDENT RISK FACTOR FOR HEPATOCELLULAR CARCINOMA RECCURENCE
Camilia MACHOU, University of Paris Est / INSERM U955, France
|
|
The POLE cohort: Multicentric prospective cohort of tumors with somatic mutation of the DNA polymerase PolE, from bed side to bench !
Nadim FARES, Cancer Research Center of Toulouse - CRCT, France
|
|
Feasibility of circulating tumour DNA quantification in early breast cancer
Hadrien Reboul, Caldas lab - Cancer Research UK Cambridge Institute, University of Cambridge, United Kingdom
|
|
Integrated analysis of H2A.Z isoforms function reveals a complex interplay in gene regulation
Assala LAMAA, CBI Toulouse, CNRS, France
|
|
NELF-mediated RNA polymerase II pausing protects genes from DSBs by facilitating the loading of Set2/Hypb H3K36 methyltransferase
David DEPIERRE, CBI-LBME, France
|
|
Resistance of Melanoma to Immune Checkpoint Inhibitors is Overcome by Targeting the Sphingosine Kinase 1
Céline COLACIOS, CRCT, France
|
|
Autophagy, a new potential therapeutic target in JAK2V617F positive Myeloproliferative Neoplasms
Charly COURDY, Centre de Recherches en Cancérologie de Toulouse (CRCT), France
|
|
Polymorphism of Heat Shock Protein 70 (HSP70-2) and bladder cancer in an Algerian population
Meriem BELHOUT ZEBIRI, University of Sciences and Technology Houari Boumediene, Algeria
|
|
First-in-class imaging approach for single-cell, real-time analysis of oncolytic virus replication and efficacy in cancer cells
Lorraine QUILLIEN, Cancer Research Centre of Toulouse (CRCT), UMR INSERM 1037, Toulouse, France, France
|
|
Selective RhoC-dependent killing of cancer cells with mesenchymal phenotype: a new determinant for parvovirus minute virus of mice oncolytic activity in PDAC
Pierre CORDELIER, Cancer Research Center of Toulouse (CRCT), UMR INSERM U1037 Team 10, Toulouse, France, France
|
|
Mechanical parameter assessment of pancreatic cancer with Magnetic Resonance Elastography
Pauline M. LEFEBVRE, CRCT UMR1037 INSERM-UNIVERSITE TOULOUSE 3 - ERL5294 CNRS , France
|
|
A better understanding of the E3 ubiquitin ligase TRIP12 heterogeneity to better treat pancreatic cancer
Manon BRUNET, Inserm U1037-CRCT, France
|
|
Role of CD36 in the response to chemotherapy in Acute Myeloid Leukemia
Thomas FARGE, INSERM, France
|
|
DeltaNp63 expression in HPV-related head and neck cancers impacts patients' prognosis, cancer cell aggressiveness and the intra-tumoral immune landscape
Alain JUNG, Centre de lutte contre le cancer Paul Strauss, France
|
|
A catalytic-independent function of the human DNA polymerase Kappa controls the pool of the checkpoint kinase Chk1
Marie-Jeanne PILLAIRE, INSERM - CRCT, France
|
|
The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities
Melissa ALAME, Institut de Recherche en Cancérologie de Montpellier, France
|
|
Conception, Preclinical and clinical validations of "Imdendrim", a new anti-cancer agent derived from the nanotechnology
Hafid BELHADJ-TAHAR, AFPREMED, France
|
|
MET exon 14 skipping mutations in lung cancer: Screening, functional and clinical impact
David TULASNE, CNRS UMR8161, France
|
|
The T cell bispecific antibody CD20-TCB shows high in vitro activity against in vivo ibrutinib-treated primary CLL samples
Anne QUILLET-MARY, CRCT, France
|
|
Bifunctional ligand design for modulating mutant P53 aggregation in cancer
Christian GAIDDON, INSERM U1113, France
|
|
Extracellular matrix gene expression and cytotoxic T lymphocyte infiltration in the tumor microenvironment in non-small cell lung cancer
Sara MILOSEVIC, Advanced Cell Diagnostics, a Bio-Techne Brand, France
|
|
JMJD6 participates in the maintenance of ribosomal DNA integrity in response to DNA damage
Yvan CANITROT, CBI LBCMCP CNRS, France
|
|
Innovative technical platform in radiochemistry and radiopharmacy (Pi-R2)
Manon PEREZ, Toulouse Neuro Imaging Center (ToNIC) UMR1214 Inserm/UPS, France
|
|
Targeting sphingosine-metabolizing enzymes: a novel strategy to bypass immune resistance in experimental melanoma
Alexandre GHENASSIA, INSERM UMR 1037 CRCT, France
|
|
Genetic variations of ABC transporters and CYP450 associated with Trabectedin hepatotoxicity in patients with advanced soft-tissue sarcomas: a pharmacogenetic study.
Maud MAILLARD, Team 14 CRCT INSERM UMR1037, France
|
|
HDAC4 levels control sensibility toward cisplatin in gastric cancer via p53/p73/BIK pathway
Georg MELLITZER, INSERM UMR_S1113, France
|
|
Modeling Cancer Initiation
Adouda ADJIRI, University FA Setif-1 Faculty of Sciences , Algeria
|
|
KDM5 histone-demethylases contribute to replication stress response and tolerance
Marie VANDROMME, CBI/LBCMCP UMR5088 CNRS/UPS, France
|
|
Senescence as an adaptive, oncogenic mechanism
Olivier COQUERET, Inserm U1232, ICO Paul Papin, France
|
|
Using DNA methylation to characterize cell types in the tumour microenvironment
Ting XIE, Inserm Centre de Recherches en Cancerologie de Toulouse, France
|
|
The adipose tissue that surrounds the prostate gland exhibits traits of hypoxic state that could contribute to its role in prostate cancer progression
David ESTEVE, Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Toulouse, France, France
|
|
Investigating pluripotency, differentiation, cancer and resistance using network representations of the genome
Vera PANCALDI, Inserm Centre de Recherches en Cancerologie de Toulouse, France
|
|
Concomitant targeting of calcium mitochondrial homeostasis and autophagy: a new strategy to increase chemosensitivity of solid cancers.
Charlotte DUBOIS, INSERM, France
|
|
Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth
Jean Philippe HUGNOT, Université de Montpellier, France
|
|
Development of an TAM targeting antibody for cancer therapy
Marcin DOMAGALA, Cancer Research Center of Toulouse, France
|
|
CD137 receptor as a candidate for therapeutic induction of high endothelial venules in solid tumors
Lucas BLANCHARD, Institut de Pharmacologie et de Biologie Structurale, France
|
|
Microtubule-associated ATIP3 deficiency sensitizes breast tumors to paclitaxel by increasing aneuploidy
Sylvie RODRIGUES-FERREIRA, Institut Gustave Roussy, France
|
|
Multiscale modelling of macrophage polarization in Chronic Lymphocytic Leukemia
Nina VERSTRAETE, Cancer Research Center of Toulouse UMR 1037 Inserm - Université Toulouse III Paul Sabatier, France
|
|
Tumor growth, progression and immune escape are modulated by ATRX alterations in pleomorphic sarcomas
Lucie DARMUSEY, CRCT, France
|
|
The Study of Synergistic and Protective Effects of Three Different Polar Saffron Extracts and Photon Radiation on Human Colorectal Cancer Cells (Ht-29) and Normal Human
Roham SALEK, mashhad univercity of medical scienses , Iran
|
|
Detection of BRAF V600E mutation by immunohistochemistry and PCR- RFLP in Moroccan patients with Pediatric Low-Grade Gliomas
Soufiane HENNANI, Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II - Casablanca, Morocco , Morocco
|
|
Phosphoantigenic activation of Vg9Vd2 T lymphocytes: involvement of RHOB in a lung cancer model
Chloé LAPLAGNE, Cancer Research Center of Toulouse - CRCT , France
|
|
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers
Thomas TROUILLARD, Medexprim, France
|
|
The histone variant macroH2A1.1 inhibits cellular migration by activating paused gene transcription in triple negative breast cancer cells.
Ludmila RECOULES, CBI, France
|
|
LungPredict: Transcriptomics and imaging to explore the lung cancer tumor microenvironment landscape, a multidisciplinary approach to personalized medicine
Vera PANCALDI, Cancer Research Center of Toulouse (CRCT), France
|